Rifaximin is a gut-specific human pregnane X receptor activator Article

Ma, Xiaochao, Shah, Yatrik M, Guo, Grace L et al. (2007). Rifaximin is a gut-specific human pregnane X receptor activator . JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 322(1), 391-398. 10.1124/jpet.107.121913

International Collaboration

cited authors

  • Ma, Xiaochao; Shah, Yatrik M; Guo, Grace L; Wang, Ting; Krausz, Kristopher W; Idle, Jeffrey R; Gonzalez, Frank J

sustainable development goals

authors

publication date

  • July 1, 2007

published in

keywords

  • BILIRUBIN DETOXIFICATION
  • COMBINATION THERAPY
  • DIVERTICULAR-DISEASE
  • DRUG-INTERACTIONS
  • GENE
  • INDUCTION
  • INFLAMMATORY-BOWEL-DISEASE
  • Life Sciences & Biomedicine
  • PATHWAYS
  • PHARMACOKINETICS
  • Pharmacology & Pharmacy
  • SMALL-INTESTINE
  • Science & Technology

Digital Object Identifier (DOI)

publisher

  • AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS

start page

  • 391

end page

  • 398

volume

  • 322

issue

  • 1